Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dermatology

Free Subscription 14.09.2026 2 Am J Dermatopathol 1 Am J Ophthalmol 4 BMC Cancer 9 Br J Dermatol 1 Cancer 1 Cancer Lett 1 Clin Dermatol 2 Clin Exp Dermatol 16 Eur J Dermatol 4 Int J Cancer 14 Int J Dermatol 2 J Cutan Pathol 10 J Dermatol 10 J Invest Dermatol 1 Mycoses 1 PLoS Comput Biol 1 PLoS Med 8 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. IBRAHIM E, Cho WC, Toruner GA, Huen A, et al
   Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma With T-Cell Receptor-Upsilondelta Phenotype and DUSP22-IRF4 Unbalanced Rearrangement: A Rare and Diagnostically Challenging Presentation.
   Am J Dermatopathol. 2026 Sep 9. doi: 10.1097/DAD.0000000000003431.
   PubMed         Abstract available
   
   
2. BAL KS, Patel NJ, Doan L, Liang S, et al
   Long-Term Outcomes Support Utilization of 23-GEP in Clinically Ambiguous Melanocytic Neoplasms.
   Am J Dermatopathol. 2026 Sep 9. doi: 10.1097/DAD.0000000000003419.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. VELDHUIS N, Achten RE, van Luijk CM, Zuithoff NPA, et al
   Dupilumab-associated ocular surface disease in atopic dermatitis: a large prospective cohort study from the BioDay registry.
   Am J Ophthalmol. 2026 Sep 8:S0002-9394(26)00508.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. MEISAMY S, Brattain K, Shao Q, Steinberger D, et al
   Measurement of metabolic activity by telemetric temperature sensing after immunotherapy and chemotherapy on three different mouse tumor models.
   BMC Cancer. 2026;26:1087.
   PubMed         Abstract available
   
   
5. ATCI MM, Erciyestepe M, Erturk K
   Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged >/= 70 years.
   BMC Cancer. 2026 Jun 25. doi: 10.1186/s12885-026-16430.
   PubMed         Abstract available
   
   
6. ANTONIO DNM, Annani-Akollor M, Fondjo LA, Anang-Quartey Y, et al
   Over-presentation of apolipoprotein E gene variants E3/E4 and cardiovascular disease risk factors among Ghanaian breast cancer patients.
   BMC Cancer. 2026 Jun 23. doi: 10.1186/s12885-026-16354.
   PubMed         Abstract available
   
   
7. MO D, Li C, Mao X, Zheng L, et al
   The clinical value of the combined detection of circulating low rectangle density neutrophils and inflammatory markers in breast cancer with lymph node metastasis.
   BMC Cancer. 2026 Jun 23. doi: 10.1186/s12885-026-16384.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

8. CARROLL E, Visan M, Herlihy M, Tobin AM, et al
   Insulin resistance in psoriasis: beyond comorbidity?
   Br J Dermatol. 2026 Sep 5:ljag383. doi: 10.1093.
   PubMed        
   
   
9. MORITA A, Zheng M, Zhang F, Shi YL, et al
   Real-world safety profile of spesolimab in generalised pustular psoriasis: expanded access programmes in Japan, China and Argentina.
   Br J Dermatol. 2026 Sep 6:ljag338. doi: 10.1093.
   PubMed        
   
   
10. LIU M, Dong P, Yang C, Xu X, et al
    Immune-Epidermal Dual Targeting in Psoriasis: Emerging Technologies and Translational Therapeutic Strategies.
    Br J Dermatol. 2026 Sep 8:ljag390. doi: 10.1093.
    PubMed         Abstract available
    
    
11. LU S, Micevic G, McGrath JA
    Personalised mRNA Therapy Comes of Age in Melanoma.
    Br J Dermatol. 2026 Sep 8:ljag378. doi: 10.1093.
    PubMed        
    
    
12. CALVAO J, Lourenco M, Martins F, Coutinho I, et al
    Primary cutaneous lymphomas: diagnostic burden and determinants of diagnostic delay across the disease spectrum.
    Br J Dermatol. 2026 Sep 8:ljag392. doi: 10.1093.
    PubMed        
    
    
13. OTTAKANDATHIL BABU R, Nahler J, Dooley K, Naidoo K, et al
    CD1a-autoreactive T cell sensing of skin barrier compromise.
    Br J Dermatol. 2026 Sep 8:ljag391. doi: 10.1093.
    PubMed         Abstract available
    
    
14. ROLAND-MCGOWAN J, Simpson EL, Leclair CM, Foster EL, et al
    Health Domains and Outcome Measurement Instruments in Adult Vulvovaginal Lichen Planus Studies: A Scoping Review.
    Br J Dermatol. 2026 Sep 10:ljag371. doi: 10.1093.
    PubMed        
    
    
15. EGGERMONT CJ, Cruts EC, van Lee CB, de Vijlder HC, et al
    Five-year Recurrence Rate of Cutaneous Squamous Cell Carcinoma After Mohs Micrographic Surgery Versus Standard Excision: a Prospective Multicentre Cohort Study.
    Br J Dermatol. 2026 Sep 10:ljag399. doi: 10.1093.
    PubMed         Abstract available
    
    
16. MA Y, Han T
    Less inflammation, greater photoprotection? Rethinking the role of the skin microbiome after ultraviolet exposure.
    Br J Dermatol. 2026 Sep 10:ljag400. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

17. MAZZITELLI N, Star J, Meggett K, Han X, et al
    Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023.
    Cancer. 2026;132:e70557.
    PubMed         Abstract available
    
    

    
    Cancer Lett

18. LIAO Y, Yin S, Peng EY, Wu J, et al
    The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.
    Cancer Lett. 2026 Aug 14:218770. doi: 10.1016/j.canlet.2026.218770.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

19. VROMANS AM, Harrop B, Flores N, Grant-Kels JM, et al
    Immune Checkpoint Inhibition in Locally Advanced, Recurrent, and Metastatic Cutaneous Squamous Cell Carcinoma.
    Clin Dermatol. 2026 Sep 12:S0738-081X(26)00235.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

20. HUGHES AM, Powell J, Abbott RA
    Frailty scoring in the management of people with skin cancer: a critically appraised topic.
    Clin Exp Dermatol. 2026 Sep 8:llag388. doi: 10.1093.
    PubMed         Abstract available
    
    
21. SAVAGE L, Gkini MA, Wang X, Topping L, et al
    Real-world Drug Survival of Guselkumab in Patients With Psoriasis Stratified by Weight and Comorbidities: Retrospective, Observational Data From the British Association of Dermatologists Biologics and Immunomodulators Register.
    Clin Exp Dermatol. 2026 Sep 8:llag363. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Dermatol

22. SHIBA M, Hagino T, Uchiyama A, Saeki H, et al
    Routine blood biomarkers associated with clinical response to tralokinumab in patients with atopic dermatitis: a 48-week real-world study in Japan.
    Eur J Dermatol. 2026;36:0.
    PubMed         Abstract available
    
    
23. VISINONI S, Efenesia Baffa M, Pipito C, Rubino V, et al
    Successful treatment of severe refractory folliculitis decalvans and lichen planopilaris phenotypic spectrum with baricitinib.
    Eur J Dermatol. 2026;36:364-365.
    PubMed        
    
    
24. FANG H, Jin J, Qi F, Li L, et al
    Misdiagnosis of an odontogenic cutaneous fistula as a first branchial cleft cyst and diagnostic insights: a paediatric case report.
    Eur J Dermatol. 2026;36:365-367.
    PubMed        
    
    
25. GIOVANNINI M, Di Calabria VR, Mori F, Oranges T, et al
    Dupilumab treatment of linear IgA bullous dermatosis in a child.
    Eur J Dermatol. 2026;36:367-369.
    PubMed        
    
    
26. SAIDA Y, Ogura Y, Yamanaka K, Honda T, et al
    Rapidly progressive alopecia areata with early recovery following discontinuation of secukinumab treatment for psoriasis.
    Eur J Dermatol. 2026;36:376-378.
    PubMed        
    
    
27. YANO D, Kaneko T, Suga Y, Mitsuishi T, et al
    Wide surgical excision and mesh split-thickness skin grafting for extensive recalcitrant anogenital warts.
    Eur J Dermatol. 2026;36:378-380.
    PubMed        
    
    
28. YAMAMOTO J, Egawa T, Asano Y
    Improvement of interstitial lung disease during brodalumab treatment in a patient with psoriasis and systemic immune-mediated inflammation.
    Eur J Dermatol. 2026;36:380-382.
    PubMed        
    
    
29. GAMBICHLER T, Ruhe C, Weyer-Fahlbusch SS, Susok L, et al
    Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors.
    Eur J Dermatol. 2026;36:384-386.
    PubMed        
    
    
30. SANCHEZ-ARJONA M, Ramos-Caballo M, Alfageme-Roldan F, Najera-Botello L, et al
    Ultrasound assessment of suspected pseudoprogression during neoadjuvant immunotherapy for desmoplastic melanoma of the scalp.
    Eur J Dermatol. 2026;36:390-392.
    PubMed        
    
    
31. ALONSO MP, Rodriguez-Sanchez B, Zamarro-Diaz LA, Gonzalez JM, et al
    sQUIZ your knowledge! Hypopigmented skin lesions in adolescence.
    Eur J Dermatol. 2026;36:395-396.
    PubMed        
    
    
32. MORTON CA, Szeimies RM, Braathen LR
    Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2025.
    Eur J Dermatol. 2026;36:307-311.
    PubMed         Abstract available
    
    
33. AGUGLIA R, Niederegger T, Satea M, Knoedler L, et al
    High-frequency high-intensity focused ultrasound (HF-HIFU) for ablation of benign, premalignant, and malignant cutaneous lesions: a systematic review.
    Eur J Dermatol. 2026;36:312-323.
    PubMed         Abstract available
    
    
34. KAMARA M, Hirata H, Morimoto T, Kawaguchi A, et al
    An innovative AI-based approach to bone mineral density assessment in psoriasis patients using routine chest X-rays.
    Eur J Dermatol. 2026;36:324-331.
    PubMed         Abstract available
    
    
35. BAYKAL C, Akturk Gozel F, Aydogan YY, Atci T, et al
    A comparison of clinical characteristics of keratoacanthomas in Muir-Torre syndrome and xeroderma pigmentosum.
    Eur J Dermatol. 2026;36:332-338.
    PubMed         Abstract available
    
    
36. CORRENTE C, Baudry A, Pedailles S
    Improving dermatology tele-expertise through physician training: evidence from a large real-world cohort.
    Eur J Dermatol. 2026;36:339-344.
    PubMed         Abstract available
    
    
37. LAPI F, Marconi E, Rossi A, Cricelli I, et al
    Epidemiology update and refractoriness to initial pharmacotherapy of chronic spontaneous urticaria: insight from an Italian primary care cohort.
    Eur J Dermatol. 2026;36:353-361.
    PubMed         Abstract available
    
    

    
    Int J Cancer

38. BLOEM M, de Meza MM, Boreel CDM, Aarts MJB, et al
    Early Cessation of Adjuvant Anti-PD-1 Therapy in Stage III and IV Melanoma.
    Int J Cancer. 2026 Sep 9. doi: 10.1002/ijc.70738.
    PubMed         Abstract available
    
    
39. KOFFKA F, Kornowski J, Laakmann E, Schmalfeldt B, et al
    Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study.
    Int J Cancer. 2026 Sep 10. doi: 10.1002/ijc.70735.
    PubMed         Abstract available
    
    
40. LIU CG, Yang J, Luo R, Sun R, et al
    Comments on "Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma".
    Int J Cancer. 2026 Sep 11. doi: 10.1002/ijc.70702.
    PubMed        
    
    
41. LE YANG R, Liang Y
    Oncotype DX: Clinical Utility, Evidence, and Future Trends in Personalized Breast Cancer Management.
    Int J Cancer. 2026 Jun 14. doi: 10.1002/ijc.70607.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

42. CHEN WG, Chen CC, Chen CY, Hsu SC, et al
    Food Allergy Testing in Atopic Dermatitis: A Purpose-First Comparison of International Guidelines.
    Int J Dermatol. 2026 Sep 8. doi: 10.1111/ijd.70669.
    PubMed         Abstract available
    
    
43. BONETE P, Buendia-Martinez C, Bea S, Abril-Perez C, et al
    Beyond Complete Response: Sonidegib Consolidation and Recurrence in Locally Advanced Basal Cell Carcinoma.
    Int J Dermatol. 2026 Sep 9. doi: 10.1111/ijd.70671.
    PubMed        
    
    
44. PLANELLA-FONTANILLAS N, Berna-Rico E, Pesque D, Andrades E, et al
    CH50 as a Clinically Useful Biomarker of Disease Activity and Antihistamine Resistance in Chronic Spontaneous Urticaria: An Observational Ambispective Single-Center Study.
    Int J Dermatol. 2026;65:2066-2073.
    PubMed         Abstract available
    
    
45. PHAM HD, Le DH, Tran TS, Le SD, et al
    Tissue Levels of MMP-9 and Granzyme B in Patients With Bullous Pemphigoid: A Case-Control Study.
    Int J Dermatol. 2026;65:2074-2080.
    PubMed         Abstract available
    
    
46. SINCLAIR R, Yang CC, Chung WH, Dhurat R, et al
    Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations.
    Int J Dermatol. 2026;65:2091-2101.
    PubMed         Abstract available
    
    
47. GAVAGAN K, Trager A, Esfandiari N, Mehregan D, et al
    CARD14-Associated Papulosquamous Eruption (CAPE): An Updated Review of Pathogenesis and Treatment.
    Int J Dermatol. 2026;65:2049-2054.
    PubMed         Abstract available
    
    
48. PIRACCINI BM, Rapparini L, Quadrelli F, Pampaloni F, et al
    Effectiveness and Safety of Topical Finasteride for Male Androgenetic Alopecia: Real World Data.
    Int J Dermatol. 2026;65:2102-2107.
    PubMed         Abstract available
    
    
49. MCMULLEN E, Hafeez DA, Pai N, Mainville L, et al
    The Gut Microbiome as a Therapeutic Target in Alopecia Areata: Not Yet Part of the Patient Treatment Plan.
    Int J Dermatol. 2026;65:2001-2004.
    PubMed         Abstract available
    
    
50. BETTOLINI L, Maronese CA, Derlino F, Genovese G, et al
    Selective IL-23 Inhibition in Conventional Treatment-Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective Study.
    Int J Dermatol. 2026;65:2055-2065.
    PubMed         Abstract available
    
    
51. CHERNYSHOV PV, Jemec G, Finlay A, Ingram JR, et al
    Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.
    Int J Dermatol. 2026;65:2008-2017.
    PubMed         Abstract available
    
    
52. KHODADAD K, Chin NE, Chovatiya R
    PDE4 Inhibition in Dermatologic Disease: Impacts Beyond Inflammation.
    Int J Dermatol. 2026;65:2038-2048.
    PubMed         Abstract available
    
    
53. KO S, Jung D, Jang Y, Park EJ, et al
    Clinicopathological Challenge: A Painful Violaceous Reticulated Patch.
    Int J Dermatol. 2026;65:2005-2007.
    PubMed         Abstract available
    
    
54. DE A, Chakraborty D, Desai S, Goncu EK, et al
    The Role of Tissue Resident Memory Cells in Immunodermatological Disorders.
    Int J Dermatol. 2026;65:2028-2037.
    PubMed         Abstract available
    
    
55. KEMENY L
    Editors Highlights-October 2026.
    Int J Dermatol. 2026;65:1995-1996.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

56. PFEFFERLE V, Vogelsberg A, Maass M, Schurch CM, et al
    Aberrant Expression of Multiple T-Cell Markers in Primary Cutaneous Follicle Center Lymphoma: A Rare Case Report.
    J Cutan Pathol. 2026 Sep 6. doi: 10.1111/cup.70207.
    PubMed         Abstract available
    
    
57. CHO SH, Lee SM, Lee JB, Yun SJ, et al
    Cutaneous Langerhans Cell Sarcoma Harboring BRAF V600E Mutation Followed by Chronic Myelomonocytic Leukemia and EBV-Positive Diffuse Large B-Cell Lymphoma.
    J Cutan Pathol. 2026 Sep 6. doi: 10.1111/cup.70208.
    PubMed         Abstract available
    
    

    
    J Dermatol

58. BABUL A, Mehta D, Soliman Y, Hussain M, et al
    Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison.
    J Dermatol. 2026;53:1395-1407.
    PubMed         Abstract available
    
    
59. KISHIBE M, Noguchi A, Matsuya M, Matsumoto K, et al
    Clinical Characteristics and Treatment Patterns of Hyperhidrosis in Northern Hokkaido: A Single-Center Retrospective Descriptive Study.
    J Dermatol. 2026;53:1267-1276.
    PubMed         Abstract available
    
    
60. KITO M, Iwaya M, Omodaka T, Yuzuriha S, et al
    MRI-Based Surgical Margin Assessment in Dermatofibrosarcoma Protuberans: Correlation With Pathological Extent.
    J Dermatol. 2026;53:1287-1295.
    PubMed         Abstract available
    
    
61. KAN T, Ryo S, Nomoto K, Mizuno H, et al
    Etoposide as Late-Line Therapy for Metastatic Extramammary Paget's Disease: A Case Series.
    J Dermatol. 2026;53:1371-1375.
    PubMed         Abstract available
    
    
62. OCHIAI S, Anzawa K, Hiramatsu Y, Shimizu A, et al
    HPV29-Associated Periungual Epidermoid/Verrucous Cyst.
    J Dermatol. 2026;53:1388-1391.
    PubMed         Abstract available
    
    
63. YOSHINO Y, Amano M, Iino S, Omoto Y, et al
    Wound, Pressure Ulcer, and Burn Guidelines (2023)-6: Guidelines for the Management of Burns, Third Edition.
    J Dermatol. 2026;53:e688-e732.
    PubMed         Abstract available
    
    
64. YE C, Gu X, Fei C, Zhou X, et al
    Hand Eczema Referred for Patch Testing: Retrospective Study in Shanghai, China From 2018 to 2023.
    J Dermatol. 2026;53:1342-1352.
    PubMed         Abstract available
    
    
65. CASCIO INGURGIO R, Alfano A, Syed A, Gargiulo L, et al
    Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.
    J Dermatol. 2026;53:1353-1357.
    PubMed         Abstract available
    
    
66. TAKAHASHI T, Takahashi T, Segawa Y, Oka K, et al
    IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients.
    J Dermatol. 2026;53:1365-1370.
    PubMed         Abstract available
    
    
67. TANAKA N, Iso A, Higashime A
    Venetoclax-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE): Implications for Diagnosis and Treatment Continuation.
    J Dermatol. 2026;53:1385-1387.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

68. SUZUKI T, Horiguchi H, Yamamura S, Torigoe D, et al
    Aging-related IgG accumulation promotes skin inflammation.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02806.
    PubMed         Abstract available
    
    
69. WEN J, Chen W, Li J, Zhang Y, et al
    A proinflammatory FOLR2-positive macrophage subtype promotes cutaneous and renal damage in systemic lupus erythematosus.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02809.
    PubMed        
    
    
70. ZHANG X, Song X, Zhu M, Yu M, et al
    Fluoxetine activates melanocyte stem cells indirectly through the epithelial 5-hydroxytryptamine (5-HT) receptor 1A/Wnt signaling to regenerate melanocytes.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02804.
    PubMed         Abstract available
    
    
71. UEDA K, Yoshioka A, Fujita H, Aoki S, et al
    Postzygotic NRAS Variants and Subsequent Copy-Neutral Loss of Heterozygosity Underlie Speckled-Pattern Formation in Nevus Spilus-Type Congenital Melanocytic Nevus.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02794.
    PubMed         Abstract available
    
    
72. SABA K, Kataria S, Shi B, Kumar U, et al
    A Bisubstrate Inhibitor of NNMT Suppresses Myofibroblast Reprogramming to Mitigate Skin Fibrosis.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02800.
    PubMed         Abstract available
    
    
73. XIA Z, Liu L, Wang T, Xue Y, et al
    Time-course blood transcriptome dynamics of TNF-alpha inhibitor therapy in a Chinese cohort with psoriasis.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02745.
    PubMed         Abstract available
    
    
74. MIRIZIO E, Werner G, Hutchins T, Sanyal A, et al
    Tfh cell communication with myeloid compartments plays a key role in the inflammatory response in localized scleroderma: insights from skin scRNA sequencing.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02784.
    PubMed         Abstract available
    
    
75. BALAJI SK, Zheng Q, Yu H, Truong J, et al
    Defensins Mediate Skin Inflammation and Itch in Psoriasis.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02805.
    PubMed         Abstract available
    
    
76. ASLANIAN FP, Halioua B, Tan J, Gu C, et al
    Real-Life Performance of the Dermatology Long-Term Life Impact Measure (DLLIM) in Atopic Dermatitis: An International Study of 15,450 Patients.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02748.
    PubMed        
    
    
77. BERNA-RICO E, Neria F, Gomez-de la Fuente E, Perez-Garcia B, et al
    Blood proteomics links systemic inflammation with early atherosclerosis in moderate-to-severe atopic dermatitis.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02743.
    PubMed         Abstract available
    
    

    
    Mycoses

78. GRIZANTE BARIAO PH, Tonani L, Alves AR, de Almeida OGG, et al
    A Multifactorial Azole Response in Clinically Relevant Fusarium Species Complexes.
    Mycoses. 2026;69:e70220.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

79. HUANG ZH, Xu Z, Hu P
    Spatially guided translation from histology images to transcriptomic profiles using foundation model-driven contrastive learning.
    PLoS Comput Biol. 2026;22:e1014762.
    PubMed         Abstract available
    
    

    
    PLoS Med

80. ZHAKPAROV D, Lunjani N, Schmid M, Moriarty K, et al
    Multimodal protective and susceptibility clusters in paediatric atopic dermatitis: A machine learning-based, data-driven observational study.
    PLoS Med. 2026;23:e1004917.
    PubMed         Abstract available
    
    

    
    PLoS One

81. WON SH, Kim YA, Suh SY, Im JH, et al
    Preferences and reasons for clothing colors in women patients and survivors of breast cancer in Korea.
    PLoS One. 2026;21:e0357499.
    PubMed         Abstract available
    
    
82. WESTER TREJO MAC, Kuijper TM, Waverijn GJ, Bajema IM, et al
    ANCA testing strategies: A single centre experience over the past decade in a large teaching hospital in the Netherlands.
    PLoS One. 2026;21:e0357495.
    PubMed         Abstract available
    
    
83. WU C, Yang Y, Wang C, Shen Y, et al
    Clinicopathological characteristics and prognosis of melanoma: A retrospective cohort study in Xinjiang, China.
    PLoS One. 2026;21:e0357383.
    PubMed         Abstract available
    
    
84. TUAN NV, Ha VT, Duong MS
    Phobic anxiety disorders among patients with acne vulgaris at a national dermatology hospital in Vietnam: Prevalence, clinical phenotype, and associated factors.
    PLoS One. 2026;21:e0357803.
    PubMed         Abstract available
    
    
85. YANG B, Zhou G, Dai J
    A bioinformatic single-cell and structure-informed framework identifies a baicalin-CA2-keratinocyte state axis in atopic dermatitis.
    PLoS One. 2026;21:e0356174.
    PubMed         Abstract available
    
    
86. VAZQUEZ-ROLDAN M, Ortiz-Ortiz KJ, Millan-Perez LI, Gierbolini-Bermudez A, et al
    The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico.
    PLoS One. 2026;21:e0357375.
    PubMed         Abstract available
    
    
87. ANDREWS J, Harkey Z, Mathena S, Galindo M, et al
    Exploring cross-category relationships between symptoms in people with hypermobile EDS (hEDS) to identify disability patterns.
    PLoS One. 2026;21:e0357565.
    PubMed         Abstract available
    
    
88. LIU Q, Ma J, Yang H, Liu N, et al
    Burden of malignant melanoma among the elderly population in East Asia from 1990 to 2023 and machine learning projection to 2040.
    PLoS One. 2026;21:e0357767.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

89. KUANG SH, Abrenica AG, Kar N, Logue JS, et al
    Targeting cholesterol-dependent Piezo1 activation impairs amoeboid migration in melanoma cells.
    Proc Natl Acad Sci U S A. 2026;123:e2607369123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum